Dow:
Nasdaq:
S&P 500:

8280.74 (-223.32)
1796.52 (-49.20)
896.42 (-26.91)

Featured Articles
Recover from Losses
Learn how to use a simply stock options strategy to cut your breakeven in half and quickly recoup losses!

How to Recession-Proof
Learn where to invest your money to minimize damage from the impending U.S. recession.

Gauge Stock Momentum
Learn how to determine when your investments have begun to lose steam to sell out before the crowd!

Research Tools
SEC Filings Analysis
Executive Compensation

CIGNA Corporation (NYSE: ) shares declined in early trading despite a bullish recommendation by CNBC's Jim Cramer on his Mad Money Lightning Round. The hedge fund manager turned television star belives that CIGNA is the best company in the healthcare industry and has been rapidly repurchasing shares. As a result, Cramer recommends selling other healthcare plays and picking up shares of this stock.

During the first quarter, CIGNA announced an 80 percent plunge in profits due to a new accounting rule for a discontinued retirement-income business. Net income dropped to $58 million from $289 million a year earlier. Operating profits for its large medical plans dropped 18%, while coverage for elderly was stagnant. Many analysts saw the past few years as a revenue growing opportunity for the industry, but CIGNA seems to be uninterested in such initiatives.

CIGNA Corporation is an investor-owned health service organization in the United States. The company's subsidiaries are providers of healthcare and related benefits, the majority of which are offered through the workplace, including healthcare products and services; group disability, life and accident insurance, and workers' compensation case management and related services. CIGNA's revenues are derived from premiums, fees, mail order pharmacy, other revenues and investment income.

Shares of CIGNA are trading down $0.55, or 1.45%, to $37.03 per share on the day.

Add to: del.icio.us | Digg